Bifogade filer
Prenumeration
Beskrivning
Land | Sverige |
---|---|
Lista | First North Stockholm |
Sektor | Hälsovård |
Industri | Läkemedel & Handel |
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, WHETHER DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, BELARUS OR ANY OTHER JURISDICTION WHERE SUCH DISTRIBUTION FURTHER REQUIRES PROSPECTUS, REGISTRATION, OR OTHER ACTIONS OTHER THAN THOSE UNDER SWEDISH LAW, ARE PROHIBITED, OR OTHERWISE CONTRARY TO APPLICABLE RULES IN SUCH JURISDICTION OR CANNOT TAKE PLACE WITHOUT APPLICATION OF EXCEPTIONS FROM SUCH ACTION. SEE THE "IMPORTANT INFORMATION" SECTION AT THE END OF THIS PRESS RELEASE.
Today, 7 June 2024, is the last day of trading in unit rights in Lipidor AB (publ)'s ("Lipidor" or the "Company") rights issue of units of up to approximately SEK 58.0 million (the "Rights Issue"). Last day of subscription is 12 June 2024. The Rights Issue was resolved by the Board of Directors in Lipidor on 10 April 2024 and approved on the Extraordinary General Meeting held on 21 May 2024.
Time plan for the Rights Issue
29 May – 7 June 2024 Trading in unit rights
29 May – 12 June 2024 Subscription period (with or without preferential right)
13 June 2024 Expected day for announcement of outcome in the Rights Issue
Advisors
Lipidor has mandated Penser by Carnegie, Carnegie Investment Bank AB (publ) and Fredersen Advokatbyrå AB as financial and legal advisors respectively in connection with the Rights Issue.